Kazia Therapeutics Ltd

Healthcare · Biotechnology

8.90$ +1.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Kazia Therapeutics Ltd (KZIA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q4 25), "Total Assets" came in at 71 million AUD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of AUD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KZIA
Line item	Q3 15	Q4 15	Q1 16	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q2 24	Q3 24	Q4 24	Q2 25	Q3 25	Q4 25
Total Assets	46	43	36	36	36	45	36	36	36	38	28	28	28	26	21	21	21	20	23	23	23	40	58	–	58	45	36	–	36	28	–	28	28	24	22	22	18	6.1	6.1	71
Current Assets	45	41	34	34	34	25	19	19	19	15	9.3	9.3	9.3	8.8	7.5	7.5	7.5	7.5	11	11	11	21	29	29	29	17	9.4	7.6	9.4	5.9	11	11	11	8.0	6.1	6.1	3.4	4.9	4.9	70
Cash	44	38	33	33	33	19	14	14	14	6.6	6.0	6.0	6.0	5.4	5.4	5.4	5.4	6.4	8.8	8.8	8.8	19	28	–	28	15	7.4	–	7.4	4.4	–	5.2	5.2	3.6	1.7	1.7	3.1	4.3	4.3	69
Cash & Short-Term Investments	44	38	33	33	33	19	14	14	14	6.6	6.0	6.0	6.0	5.4	5.4	5.4	5.4	6.4	8.8	8.8	8.8	19	28	–	28	15	7.4	–	7.4	4.4	–	5.2	5.2	3.6	–	1.7	3.1	–	4.3	69
Receivables	0.0	0.2	–	0.1	0.1	0.4	4.1	4.1	0.0	0.2	1.8	2.3	0.0	3.1	0.1	1.6	1.6	0.9	1.2	1.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	–	0.1	0.3
Inventory	–	–	–	0.4	0.4	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	0.0	–	–	–	–	–	–	–	–	–	–	–	-0.1	-0.1	–	–	–	–	–	–
Property, Plant & Equipment	–	0.4	–	0.4	0.6	0.4	0.5	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	1.4	1.1	0.8	0.8	0.8	20	16	16	16	15	15	15	15	14	13	13	13	13	12	12	12	12	22	–	22	21	19	–	19	18	–	17	17	16	15	15	14	1.1	1.1	1.1
Total Liabilities	1.8	1.7	1.4	1.6	1.6	14	5.4	11	11	12	3.9	8.9	8.9	7.2	1.9	7.0	7.0	8.2	5.1	8.9	8.9	7.9	8.3	–	20	19	6.7	–	18	16	–	16	16	19	32	32	22	14	14	25
Current Liabilities	1.8	1.5	1.4	1.4	1.4	2.5	5.4	5.4	5.4	7.1	3.9	3.9	3.9	2.4	1.9	1.9	2.2	3.1	5.1	5.1	5.1	2.7	8.3	8.3	8.3	7.6	6.7	4.7	6.7	5.6	7.6	7.6	7.6	11	26	26	17	14	14	24
Short-Term Debt	–	–	–	0.0	0.0	–	–	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	1.8	0.6	–	1.8	1.8	0.4	–	0.6	0.1	–	0.4	0.1
Accounts Payable	0.8	1.4	0.5	0.5	0.5	2.4	1.2	1.2	1.2	2.8	1.4	1.4	1.4	2.3	1.1	1.1	1.1	2.9	1.7	1.7	1.7	2.5	1.9	1.9	1.9	2.3	1.5	1.5	1.5	2.3	0.9	0.9	0.9	1.0	4.5	4.5	6.3	5.6	5.6	6.1
Long-Term Debt	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	45	42	31	34	34	32	23	25	25	26	17	19	19	18	12	14	14	12	13	14	14	32	36	–	38	25	16	–	18	12	–	12	12	5.3	-10	-10	-3.8	-8.3	-8.3	46
Retained Earnings	-148	-152	-161	-161	-161	-164	-171	-171	-171	-8.3	-15	-15	-15	-21	-25	-25	-25	-31	-36	-36	-36	-42	-44	-44	-44	-57	-69	-68	-69	-82	-89	-89	-89	-98	-115	-115	-125	-135	-135	-145
Shares Outstanding	0.1	0.1	43	341	0.1	0.1	48	2,799	0.1	0.1	48	157	0.1	0.1	62	339	0.1	0.1	81	14	0.2	0.2	128	–	0.3	0.3	133	146	0.3	0.3	223	236	0.5	0.5	333	0.6	0.9	809	1.6	3.1

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings